Sep 21, 2023 9:10am EDT Lexaria to Evaluate Impact of DehydraTECH on Oral Performance of GLP-1 drugs used in products such as Ozempic, Wegovy and Rybelsus, Alone or Together with DehydraTECH-CBD
Aug 02, 2023 9:10am EDT Lexaria’s Plans to Study Weight Loss and Diabetes Control in a Human Clinical Study with DehydraTECH-CBD
Jul 28, 2023 9:10am EDT Lexaria Incorporates New Subsidiary for CPG Products and Updates Human Nicotine Study
Jul 19, 2023 9:05am EDT Lexaria Granted Strategically Important New US Patent For DehydraTECH-Nicotine Including Oral Pouch Products
Jun 22, 2023 9:25am EDT Lexaria's Groundbreaking Research into DehydraTECH-CBD Published in International Journal of Molecular Science
Jun 16, 2023 9:10am EDT Lexaria’s DehydraTECH-CBD Lowers Blood Glucose Levels in Diabetes Animal Study
